|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Perry N, Broeders M, de Wolf C, Törnberg
S, Holland R and von Karsa L: European guidelines for quality
assurance in breast cancer screening and diagnosis Fourth edition -
summary document. Ann Oncol. 19:614–622. 2008. View Article : Google Scholar
|
|
3
|
Sant M, Allemani C, Capocaccia R,
Hakulinen T, Aareleid T, Coebergh JW, Coleman MP, Grosclaude P,
Martinez C, Bell J, et al; EUROCARE Working Group. Stage at
diagnosis is a key explanation of differences in breast cancer
survival across Europe. Int J Cancer. 106:416–422. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Armstrong K, Moye E, Williams S, Berlin JA
and Reynolds EE: Screening mammography in women 40 to 49 years of
age: A systematic review for the American College of Physicians.
Ann Intern Med. 146:516–526. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saslow D, Boetes C, Burke W, Harms S,
Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S, et al;
American Cancer Society Breast Cancer Advisory Group. American
Cancer Society guidelines for breast screening with MRI as an
adjunct to mammography. CA Cancer J Clin. 57:75–89. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sabatino SA, Burns RB, Davis RB, Phillips
RS, Chen YH and McCarthy EP: Breast carcinoma screening and risk
perception among women at increased risk for breast carcinoma:
Results from a national survey. Cancer. 100:2338–2346. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Evans JP, Skrzynia C, Susswein L and
Harlan M: Genetics and the young woman with breast cancer. Breast
Dis. 23:17–29. 2006.PubMed/NCBI
|
|
8
|
Klauber-DeMore N: Tumor biology of breast
cancer in young women. Breast Dis. 23:9–15. 2006.PubMed/NCBI
|
|
9
|
Kurian AW, Hartman AR, Mills MA, Ford JM,
Daniel BL and Plevritis SK: Opinions of women with high inherited
breast cancer risk about prophylactic mastectomy: An initial
evaluation from a screening trial including magnetic resonance
imaging and ductal lavage. Health Expect. 8:221–233. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Clements A, Henderson BJ, Tyndel S, Evans
G, Brain K, Austoker J and Watson E; PIMMS Study Management Group.
Diagnosed with breast cancer while on a family history screening
programme: An exploratory qualitative study. Eur J Cancer Care
(Engl). 17:245–252. 2008. View Article : Google Scholar
|
|
11
|
Bermejo-Pérez MJ, Márquez-Calderón S and
Llanos-Méndez A: Cancer surveillance based on imaging techniques in
carriers of BRCA1/2 gene mutations: A systematic review. Br J
Radiol. 81:172–179. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Willey SC and Cocilovo C: Screening and
follow-up of the patient at high risk for breast cancer. Obstet
Gynecol. 110:1404–1416. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Armstrong AC and Evans GD: Management of
women at high risk of breast cancer. BMJ. 348:g27562014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Anderson E, Berg J, Black R, Bradshaw N,
Campbell J, Cetnarskyj R, Drummond S, Davidson R, Dunlop J, Fordyce
A, et al: Predicting breast cancer risk: Implications of a ‘weak'
family history. Fam Cancer. 7:361–366. 2008. View Article : Google Scholar
|
|
15
|
Eerola H, Blomqvist C, Pukkala E, Pyrhönen
S and Nevanlinna H: Familial breast cancer in southern Finland: How
prevalent are breast cancer families and can we trust the family
history reported by patients? Eur J Cancer. 36:1143–1148. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Møller P, Hagen AI, Apold J, Maehle L,
Clark N, Fiane B, Løvslett K, Hovig E and Vabø A: Genetic
epidemiology of BRCA mutations - family history detects less than
50% of the mutation carriers. Eur J Cancer. 43:1713–1717. 2007.
View Article : Google Scholar
|
|
17
|
Fackenthal JD and Olopade OI: Breast
cancer risk associated with BRCA1 and BRCA2 in diverse populations.
Nat Rev Cancer. 7:937–948. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harboe TL, Eiberg H, Kern P, Ejlertsen B,
Nedergaard L, Timmermans-Wielenga V, Nielsen IM and Bisgaard ML: A
high frequent BRCA1 founder mutation identified in the Greenlandic
population. Fam Cancer. 8:413–419. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ferla R, Calò V, Cascio S, Rinaldi G,
Badalamenti G, Carreca I, Surmacz E, Colucci G, Bazan V and Russo
A: Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol. 18(Suppl
6): vi93–vi98. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Iyevleva AG, Suspitsin EN, Kroeze K,
Gorodnova TV, Sokolenko AP, Buslov KG, Voskresenskiy DA, Togo AV,
Kovalenko SP, Stoep N, et al: Non-founder BRCA1 mutations in
Russian breast cancer patients. Cancer Lett. 298:258–263. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sagi M, Eilat A, Ben Avi L, Goldberg Y,
Bercovich D, Hamburger T, Peretz T and Lerer I: Two BRCA1/2 founder
mutations in Jews of Sephardic origin. Fam Cancer. 10:59–63. 2011.
View Article : Google Scholar
|
|
22
|
Manchanda R, Legood R, Burnell M, McGuire
A, Raikou M, Loggenberg K, Wardle J, Sanderson S, Gessler S, Side
L, et al: Cost-effectiveness of population screening for BRCA
mutations in Ashkenazi jewish women compared with family
history-based testing. J Natl Cancer Inst. 107:3802015. View Article : Google Scholar
|
|
23
|
Corbex M, Bouzbid S and Boffetta P:
Features of breast cancer in developing countries, examples from
North-Africa. Eur J Cancer. 50:1808–1818. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Weitzel JN, Lagos VI, Cullinane CA, Gambol
PJ, Culver JO, Blazer KR, Palomares MR, Lowstuter KJ and MacDonald
DJ: Limited family structure and BRCA gene mutation status in
single cases of breast cancer. JAMA. 297:2587–2595. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Leu M, Czene K and Reilly M: The impact of
truncation and missing family links in population-based registers
on familial risk estimates. Am J Epidemiol. 166:1461–1467. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Leu M, Czene K and Reilly M: Bias
correction of estimates of familial risk from population-based
cohort studies. Int J Epidemiol. 39:80–88. 2010. View Article : Google Scholar
|
|
27
|
Weitzel JN: Limited Family structure and
breast cancer risk. JAMA. 298:Letter. 2007, http://dx.doi.org/10.1001/jama.298.17.2007-b.
View Article : Google Scholar
|
|
28
|
Cohen M and Azaiza F: Early breast cancer
detection practices, health beliefs, and cancer worries in Jewish
and Arab women. Prev Med. 41:852–858. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Goel MS, Wee CC, McCarthy EP, Davis RB,
Ngo-Metzger Q and Phillips RS: Racial and ethnic disparities in
cancer screening: The importance of foreign birth as a barrier to
care. J Gen Intern Med. 18:1028–1035. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li CI, Malone KE and Daling JR:
Differences in breast cancer stage, treatment, and survival by race
and ethnicity. Arch Intern Med. 163:49–56. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lagerlund M, Maxwell AE, Bastani R,
Thurfjell E, Ekbom A and Lambe M: Sociodemographic predictors of
non-attendance at invitational mammography screening - a
population-based register study (Sweden). Cancer Causes Control.
13:73–82. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sassi F, Luft HS and Guadagnoli E:
Reducing racial/ethnic disparities in female breast cancer:
Screening rates and stage at diagnosis. Am J Public Health.
96:2165–2172. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Terán L, Baezconde-Garbanati L, Márquez M,
Castellanos E and Belkić K: On-time mammography screening with a
focus on Latinas with low income: A proposed cultural model.
Anticancer Res. 27(6C): 4325–4338. 2007.
|
|
34
|
Belkić K, Cohen M, Márquez M, Mints M,
Wilczek B, Berman AH, Castellanos E and Castellanos M: Screening of
high-risk groups for breast and ovarian cancer in Europe: A focus
on the Jewish population. Oncol Rev. 4:233–267. 2010. View Article : Google Scholar
|
|
35
|
Sándor J, Havasi V, Kiss I, Szücs M,
Brázay L, Sebestyén A and Ember I: Small area inequalities in
breast cancer mortality and screening. Magy Onkol. 46:139–145.
2002.(In Hungarian).
|
|
36
|
Copson E, Maishman T, Gerty S, Eccles B,
Stanton L, Cutress RI, Altman DG, Durcan L, Simmonds P, Jones L, et
al; POSH study steering group. Ethnicity and outcome of young
breast cancer patients in the United Kingdom: The POSH study. Br J
Cancer. 110:230–241. 2014. View Article : Google Scholar :
|
|
37
|
den Heijer M, Seynaeve C, Vanheusden K,
Timman R, Duivenvoorden HJ, Tilanus-Linthorst M, Menke-Pluijmers MB
and Tibben A: Long-term psychological distress in women at risk for
hereditary breast cancer adhering to regular surveillance: A risk
profile. Psychooncology. 22:598–604. 2013. View Article : Google Scholar
|
|
38
|
Essink-Bot ML, Rijnsburger AJ, van Dooren
S, de Koning HJ and Seynaeve C: Women's acceptance of MRI in breast
cancer surveillance because of a familial or genetic
predisposition. Breast. 15:673–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kriege M, Brekelmans CT, Boetes C, Rutgers
EJ, Oosterwijk JC, Tollenaar RA, Manoliu RA, Holland R, de Koning
HJ and Klijn JG: MRI screening for breast cancer in women with
familial or genetic predisposition: Design of the Dutch National
Study (MRISC). Fam Cancer. 1:163–168. 2001. View Article : Google Scholar
|
|
40
|
Kriege M, Brekelmans CTM, Boetes C,
Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse
H, Tilanus-Linthorst MM, et al; Magnetic Resonance Imaging
Screening Study Group. Efficacy of MRI and mammography for
breast-cancer screening in women with a familial or genetic
predisposition. N Engl J Med. 351:427–437. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kriege M, Brekelmans CT, Boetes C, Muller
SH, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Rutgers EJ, de
Koning HJ, et al; Dutch MRI Screening (MRISC) Study Group.
Differences between first and subsequent rounds of the MRISC breast
cancer screening program for women with a familial or genetic
predisposition. Cancer. 106:2318–2326. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kriege M, Brekelmans CT, Peterse H,
Obdeijn IM, Boetes C, Zonderland HM, Muller SH, Kok T, Manoliu RA,
Besnard AP, et al: Tumor characteristics and detection method in
the MRISC screening program for the early detection of hereditary
breast cancer. Breast Cancer Res Treat. 102:357–363. 2007.
View Article : Google Scholar
|
|
43
|
Obdeijn IM, Loo CE, Rijnsburger AJ, Wasser
MN, Bergers E, Kok T, Klijn JG and Boetes C: Assessment of
false-negative cases of breast MR imaging in women with a familial
or genetic predisposition. Breast Cancer Res Treat. 119:399–407.
2010. View Article : Google Scholar
|
|
44
|
Pieterse K, van Dooren S, Seynaeve C,
Bartels CC, Rijnsburger AJ, de Koning HJ, Klijn JG, van Elderen T,
Tibben A and Duivenvoorden HJ: Passive coping and psychological
distress in women adhering to regular breast cancer surveillance.
Psychooncology. 16:851–858. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rijnsburger AJ, Obdeijn I-M, Kaas R,
Tilanus-Linthorst MMA, Boetes C, Loo CE, Wasser MN, Bergers E, Kok
T, Muller SH, et al: BRCA1-associated breast cancers present
differently from BRCA2-associated and familial cases: Long-term
follow-up of the Dutch MRISC Screening Study. J Clin Oncol.
28:5265–5273. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tilanus-Linthorst MM, Kriege M, Boetes C,
Hop WC, Obdeijn IM, Oosterwijk JC, Peterse HL, Zonderland HM,
Meijer S, Eggermont AM, et al: Hereditary breast cancer growth
rates and its impact on screening policy. Eur J Cancer.
41:1610–1617. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Albada A, Werrett J, Van Dulmen S, Bensing
JM, Chapman C, Ausems MG and Metcalfe A: Breast cancer genetic
counselling referrals: How comparable are the findings between the
UK and the Netherlands? J Community Genet. 2:233–247. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Boetes C: Update on screening breast MRI
in high-risk women. Obstet Gynecol Clin North Am. 38:149–158.
viii–ix. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lammens CR, Bleiker EM, Aaronson NK,
Wagner A, Sijmons RH, Ausems MG, Vriends AH, Ruijs MW, van Os TA,
Spruijt L, et al: Regular surveillance for Li-Fraumeni Syndrome:
Advice, adherence and perceived benefits. Fam Cancer. 9:647–654.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Fakkert IE, Jansen L, Meijer K, Kok T,
Oosterwijk JC, Mourits MJ and de Bock GH: Breast cancer screening
in BRCA1 and BRCA2 mutation carriers after risk reducing
salpingo-oophorectomy. Breast Cancer Res Treat. 129:157–164. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tilanus-Linthorst MM, Obdeijn IM, Bartels
KC, de Koning HJ and Oudkerk M: First experiences in screening
women at high risk for breast cancer with MR imaging. Breast Cancer
Res Treat. 63:53–60. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Brown J, Coulthard A, Dixon AK, Dixon JM,
Easton DF, Eeles RA, Evans DG, Gilbert FG, Hayes C, Jenkins JP, et
al; UK MRI Breast Screening Study Advisory Group. Protocol for a
national multi-centre study of magnetic resonance imaging screening
in women at genetic risk of breast cancer. Breast. 9:78–82. 2000.
View Article : Google Scholar
|
|
53
|
Brown J, Coulthard A, Dixon AK, Dixon JM,
Easton DF, Eeles RA, Evans DG, Gilbert FG, Hayes C, Jenkins JP, et
al; UK MRI Breast Screening Study Advisory Group. Rationale for a
national multi-centre study of magnetic resonance imaging screening
in women at genetic risk of breast cancer. Breast. 9:72–77. 2000.
View Article : Google Scholar
|
|
54
|
Brown J, Buckley D, Coulthard A, Dixon AK,
Dixon JM, Easton DF, Eeles RA, Evans DG, Gilbert FG, Graves M, et
al; UK MRI Breast Screening Study Advisory Group. Magnetic
resonance imaging screening in women at genetic risk of breast
cancer: Imaging and analysis protocol for the UK multicentre study.
Magn Reson Imaging. 18:765–776. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Evans DG, Lennard F, Pointon LJ, Ramus SJ,
Gayther SA, Sodha N, Kwan-Lim GE, Leach MO, Warren R, Thompson D,
et al; UK Study of MRI Screening for Breast Cancer in Women at High
Risk (MARIBS). Eligibility for magnetic resonance imaging screening
in the United Kingdom: Effect of strict selection criteria and
anonymous DNA testing on breast cancer incidence in the MARIBS
Study. Cancer Epidemiol Biomarkers Prev. 18:2123–2131. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Evans DG, Brentnall AR, Harvie M, Dawe S,
Sergeant JC, Stavrinos P, Astley S, Wilson M, Ainsworth J, Cuzick
J, et al: Breast cancer risk in young women in the national breast
screening programme: Implications for applying NICE guidelines for
additional screening and chemoprevention. Cancer Prev Res (Phila).
7:993–1001. 2014. View Article : Google Scholar
|
|
57
|
Evans DG, Kesavan N, Lim Y, Gadde S,
Hurley E, Massat NJ, Maxwell AJ, Ingham S, Eeles R, Leach MO, et
al; MARIBS Group. MRI breast screening in high-risk women: Cancer
detection and survival analysis. Breast Cancer Res Treat.
145:663–672. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Gilbert FJ, Warren RM, Kwan-Lim G,
Thompson DJ, Eeles RA, Evans DG and Leach MO; United Kingdom
Magnetic Resonance Imaging in Breast Screening (MARIBS) Study
Group. Cancers in BRCA1 and BRCA2 carriers and in women at high
risk for breast cancer: MR imaging and mammographic features.
Radiology. 252:358–368. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Griebsch I, Brown J, Boggis C, Dixon A,
Dixon M, Easton D, Eeles R, Evans DG, Gilbert FJ, Hawnaur J, et al;
UK Magnetic Resonance Imaging in Breast Screening (MARIBS) Study
Group. Cost-effectiveness of screening with contrast enhanced
magnetic resonance imaging vs X-ray mammography of women at a high
familial risk of breast cancer. Br J Cancer. 95:801–810. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Gui GP, Hogben RK, Walsh G, A'Hern R and
Eeles R: The incidence of breast cancer from screening women
according to predicted family history risk: Does annual clinical
examination add to mammography? Eur J Cancer. 37:1668–1673. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Gui GP, Kadayaprath G, Darhouse N, Self J,
Ward A, A'Hern R and Eeles R: Clinical outcome and service
implications of screening women at increased breast cancer risk
from a family history. Eur J Surg Oncol. 32:719–724. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Hutton J, Walker LG, Gilbert FJ, Evans DG,
Eeles R, Kwan-Lim GE, Thompson D, Pointon LJ, Sharp DM and Leach
MO; UK Study Group for MRI Screening in Women at High Risk Study.
Psychological impact and acceptability of magnetic resonance
imaging and X-ray mammography: The MARIBS Study. Br J Cancer.
104:578–586. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Leach MO, Eeles RA, Turnbull LW, Dixon AK,
Brown J, Hoff RJ, Coulthard A, Dixon JM, Easton DF, Evans DG, et
al; Magnetic Resonance Imaging as a Method of Screening for Breast
Cancer Advisory Group. The UK national study of magnetic resonance
imaging as a method of screening for breast cancer (MARIBS). J Exp
Clin Cancer Res. 21(Suppl 3): 107–114. 2002.
|
|
64
|
Leach MO, Boggis CR, Dixon AK, Easton DF,
Eeles RA, Evans DG, Gilbert FJ, Griebsch I, Hoff RJ, Kessar P, et
al; MARIBS study group. Screening with magnetic resonance imaging
and mammography of a UK population at high familial risk of breast
cancer: A prospective multicentre cohort study (MARIBS). Lancet.
365:1769–1778. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Thompson DJ, Leach MO, Kwan-Lim G, Gayther
SA, Ramus SJ, Warsi I, Lennard F, Khazen M, Bryant E, Reed S, et
al; UK study of MRI screening for breast cancer in women at high
risk (MARIBS). Assessing the usefulness of a novel MRI-based breast
density estimation algorithm in a cohort of women at high genetic
risk of breast cancer: The UK MARIBS study. Breast Cancer Res.
11:R802009. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Tilanus-Linthorst MM, Obdeijn IM and
Bartels KC: MARIBS study. Lancet. 366:291–292. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Warren RM, Thompson D, Pointon LJ, Hoff R,
Gilbert FJ, Padhani AR, Easton DF, Lakhani SR and Leach MO;
Collaborators in the United Kingdom Medical Research Council
Magnetic Resonance Imaging in Breast Screening (MARIBS) Study.
Evaluation of a prospective scoring system designed for a
multicenter breast MR imaging screening study. Radiology.
239:677–685. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Gilbert FJ: Breast cancer screening in
high risk women. Cancer Imaging. 8(Spec No A): S6–S9.
2008.http://dx.doi.org/10.1102/1470-7330.2008.9002.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Leach MO: Breast cancer screening in women
at high risk using MRI. NMR Biomed. 22:17–27. 2009. View Article : Google Scholar
|
|
70
|
Murday V, Pears R, Ball J, Eeles R and
Hodgson S: An audit of screening for familial breast cancer before
50 years in the South Thames Region - have we got it right? Fam
Cancer. 3:29–34. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Kollias J, Sibbering DM, Blamey RW,
Holland PA, Obuszko Z, Wilson AR, Evans AJ, Ellis IO and Elston CW:
Screening women aged less than 50 years with a family history of
breast cancer. Eur J Cancer. 34:878–883. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Reis MM, Tavakoli M, Dewar J, Goudie D,
Cook A, McLeish L, Young D, Kenyon J and Steel M: Evaluation of a
surveillance programme for women with a family history of breast
cancer. J Med Genet. 46:319–323. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Brain K, Henderson BJ, Tyndel S, Bankhead
C, Watson E, Clements A and Austoker J; PIMMS Study Management
Group. Predictors of breast cancer-related distress following
mammography screening in younger women on a family history breast
screening programme. Psychooncology. 17:1180–1188. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Tyndel S, Clements A, Bankhead C,
Henderson BJ, Brain K, Watson E and Austoker J; PIMMS Study
Management Group. Mammographic screening for young women with a
family history of breast cancer: Knowledge and views of those at
risk. Br J Cancer. 99:1007–1012. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Evans DG, Harvie M, Bundred N and Howell
A: Uptake of breast cancer prevention and screening trials. J Med
Genet. 47:853–855. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Howell SJ, Searle C, Goode V, Gardener T,
Linton K, Cowan RA, Harris MA, Hopwood P, Swindell R, Norman A, et
al: The UK national breast cancer screening programme for survivors
of Hodgkin lymphoma detects breast cancer at an early stage. Br J
Cancer. 101:582–588. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Evans DG, Thomas S, Caunt J, Roberts L,
Howell A, Wilson M, Fox R, Sibbering DM, Moss S, Wallis MG, et al;
FH02 study group. Mammographic surveillance in women aged 35–39 at
enhanced familial risk of breast cancer (FH02). Fam Cancer.
13:13–21. 2014. View Article : Google Scholar
|
|
78
|
Schmutzler RK, Rhiem K, Breuer P,
Wardelmann E, Lehnert M, Coburger S and Wappenschmidt B: Outcome of
a structured surveillance programme in women with a familial
predisposition for breast cancer. Eur J Cancer Prev. 15:483–489.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Kuhl CK: High-risk screening:
Multi-modality surveillance of women at high risk for breast cancer
(proven or suspected carriers of a breast cancer susceptibility
gene). J Exp Clin Cancer Res. 21(Suppl 3): 103–106. 2002.
|
|
80
|
Kuhl CK, Schrading S, Leutner CC,
Morakkabati-Spitz N, Wardelmann E, Fimmers R, Kuhn W and Schild HH:
Mammography, breast ultrasound, and magnetic resonance imaging for
surveillance of women at high familial risk for breast cancer. J
Clin Oncol. 23:8469–8476. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Kuhl CK, Kuhn W and Schild H: Management
of women at high risk for breast cancer: New imaging beyond
mammography. Breast. 14:480–486. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Schrading S and Kuhl CK: Mammographic, US,
and MR imaging phenotypes of familial breast cancer. Radiology.
246:58–70. 2008. View Article : Google Scholar
|
|
83
|
Meindl A; German Consortium for Hereditary
Breast and Ovarian Cancer. Comprehensive analysis of 989 patients
with breast or ovarian cancer provides BRCA1 and BRCA2 mutation
profiles and frequencies for the German population. Int J Cancer.
97:472–480. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Lux MP, Ackermann S, Nestle-Krämling C,
Goecke TO, Niederacher D, Bodden-Heidrich R, Bender HG, Beckmann MW
and Fasching PA: Use of intensified early cancer detection in
high-risk patients with familial breast and ovarian cancer. Eur J
Cancer Prev. 14:399–411. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Lux MP, Ackermann S, Bani MR,
Nestle-Krämling C, Goecke TO, Niederacher D, Bodden-Heidrich R,
Bender HG, Beckmann MW and Fasching PA: Age of uptake of early
cancer detection facilities by low-risk and high-risk patients with
familial breast and ovarian cancer. Eur J Cancer Prev. 14:503–511.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Sardanelli F, Podo F, D'Agnolo G,
Verdecchia A, Santaquilani M, Musumeci R, Trecate G, Manoukian S,
Morassut S, de Giacomi C, et al; High Breast Cancer Risk Italian
Trial. Multicenter comparative multimodality surveillance of women
at genetic-familial high risk for breast cancer (HIBCRIT study):
Interim results. Radiology. 242:698–715. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Sardanelli F, Podo F, Santoro F, Manoukian
S, Bergonzi S, Trecate G, Vergnaghi D, Federico M, Cortesi L,
Corcione S, et al; High Breast Cancer Risk Italian 1 (HIBCRIT-1)
Study. Multicenter surveillance of women at high genetic breast
cancer risk using mammography, ultrasonography, and
contrast-enhanced magnetic resonance imaging (the high breast
cancer risk Italian 1 study): Final results. Invest Radiol.
46:94–105. 2011. View Article : Google Scholar
|
|
88
|
Sardanelli F, Giuseppetti GM, Canavese G,
Cataliotti L, Corcione S, Cossu E, Federico M, Marotti L,
Martincich L, Panizza P, et al: Indications for breast magnetic
resonance imaging. Consensus document ‘Attualità in senologia',
Florence 2007. Radiol Med (Torino). 113:1085–1095. 2008. View Article : Google Scholar
|
|
89
|
Manfrin E, Mariotto R, Remo A, Reghellin
D, Falsirollo F, Dalfior D, Bricolo P, Piazzola E and Bonetti F:
Benign breast lesions at risk of developing cancer--a challenging
problem in breast cancer screening programs: Five years' experience
of the Breast Cancer Screening Program in Verona (1999–2004).
Cancer. 115:499–507. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Santoro F, Podo F and Sardanelli F: MRI
screening of women with hereditary predisposition to breast cancer:
Diagnostic performance and survival analysis. Breast Cancer Res
Treat. 147:685–687. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Cortesi L, Turchetti D, Marchi I, Fracca
A, Canossi B, Rachele B, Silvia R, Rita PA, Pietro T and Massimo F:
Breast cancer screening in women at increased risk according to
different family histories: An update of the Modena Study Group
experience. BMC Cancer. 6:2102006. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Cortesi L, Pecchi A, De Matteis E, Filieri
E, Battista R, Canossi B, Torricelli P and Federico M: MRI in high
risk women: Benefits and problems. Eur J Radiol. 81(Suppl 1):
S19–S20. 2012. View Article : Google Scholar
|
|
93
|
Federico M, Maiorana A, Mangone L,
Turchetti D, Canossi B, Cortesi L, Romagnoli R and Silingardi V:
Identification of families with hereditary breast and ovarian
cancer for clinical and mammographic surveillance: The Modena Study
Group proposal. Breast Cancer Res Treat. 55:213–221. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Cortesi L, Masini C, Cirilli C, Medici V,
Marchi I, Cavazzini G, Pasini G, Turchetti D and Federico M:
Favourable ten-year overall survival in a Caucasian population with
high probability of hereditary breast cancer. BMC Cancer.
10:902010. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Trecate G, Vergnaghi D, Manoukian S,
Bergonzi S, Scaperrotta G, Marchesini M, Ferranti C, Peissel B,
Spatti G, Bohm S, et al: MRI in the early detection of breast
cancer in women with high genetic risk. Tumori. 92:517–523.
2006.
|
|
96
|
Gronwald J, Byrski T, Huzarski T, Cybulski
C, Stawicka M, Szwiec M, Debniak T, Tulman A, Sun P, Oszurek O, et
al: A survey of preventive measures among BRCA1 mutation carriers
from Poland. Clin Genet. 71:153–157. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Górski B, Jakubowska A, Huzarski T, Byrski
T, Gronwald J, Grzybowska E, Mackiewicz A, Stawicka M, Bebenek M,
Sorokin D, et al: A high proportion of founder BRCA1 mutations in
Polish breast cancer families. Int J Cancer. 110:683–686. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Brozek I, Cybulska C, Ratajska M,
Piatkowska M, Kluska A, Balabas A, Dabrowska M, Nowakowska D,
Niwinska A, Pamula-Pilat J, et al: Prevalence of the most frequent
BRCA1 mutations in Polish population. J Appl Genet. 52:325–330.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Popiela TJ, Kibil W, Herman-Sucharska I
and Urbanik A: The use of magnetic resonance mammography in women
at increased risk for developing breast cancer. Wideochir Inne Tech
Malo Inwazyjne. 8:55–62. 2013.PubMed/NCBI
|
|
100
|
Brédart A, Kop JL, Fall M, Pelissier S,
Simondi C, Dolbeault S, Livartowski A and Tardivon A; Magnetic
Resonance Imaging study group (STIC IRM 2005). Anxiety and specific
distress in women at intermediate and high risk of breast cancer
before and after surveillance by magnetic resonance imaging and
mammography versus standard mammography. Psychooncology.
21:1185–1194. 2012. View Article : Google Scholar
|
|
101
|
Brédart A, Kop JL, Fall M, Pelissier S,
Simondi C, Dolbeault S, Livartowski A and Tardivon A; Magnetic
Resonance Imaging study group (STIC IRM 2005). Perception of care
and experience of examination in women at risk of breast cancer
undergoing intensive surveillance by standard imaging with or
without MRI. Patient Educ Couns. 86:405–413. 2012. View Article : Google Scholar
|
|
102
|
Daguet E, Malhaire C, Hardit C, Athanasiou
A, El Khoury C, Thibault F, Ollivier L and Tardivon A; Groupe
Femmes à Risque de l'Institut Curie. MR breast screening in
patients with genetic mutation. J Radiol. 89:783–790. 2008.(In
French). View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Dorval M, Noguès C, Berthet P, Chiquette
J, Gauthier-Villars M, Lasset C, Picard C, Plante M, Simard J and
Julian-Reynier C; INHERIT BRCAs; GENEPSO Cohort. Breast and ovarian
cancer screening of non-carriers from BRCA1/2 mutation-positive
families: 2-year follow-up of cohorts from France and Quebec. Eur J
Hum Genet. 19:494–499. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Eisinger F, Bressac B, Castaigne D, Cottu
PH, Lansac J, Lefranc JP, Lesur A, Noguès C, Pierret J, Puy-Pernias
S, et al: Identification and management of hereditary
predisposition to cancer of the breast and the ovary (update 2004).
Bull Cancer. 91:219–237. 2004.(In French). PubMed/NCBI
|
|
105
|
Eisinger F: Breast cancer screening for
women with a strong familial risk. Bull Cancer. 92:874–884.
2005.(In French). PubMed/NCBI
|
|
106
|
Lapierre-Combes M, Rousset J, Combes E,
Chinelatto S, Dupré PF and André V: Retrospective study conducted
in northern Finistère about the role of breast MRI in normal breast
screening, experience in 51 patients. Gynecol Obstet Fertil.
37:401–409. 2009.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Riedl CC, Ponhold L, Flöry D, Weber M,
Kroiss R, Wagner T, Fuchsjäger M and Helbich TH: Magnetic resonance
imaging of the breast improves detection of invasive cancer,
preinvasive cancer, and premalignant lesions during surveillance of
women at high risk for breast cancer. Clin Cancer Res.
13:6144–6152. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Kroiss R, Winkler V, Bikas D, Fleischmann
E, Mainau C, Frommlet F, Muhr D, Fuerhauser C, Tea M, Bittner B, et
al; Austrian Hereditary Breast and Ovarian Cancer Group. Younger
birth cohort correlates with higher breast and ovarian cancer risk
in European BRCA1 mutation carriers. Hum Mutat. 26:583–589. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Kroiss R, Winkler V, Kalteis K, Bikas D,
Rudas M, Tea M, Fuerhauser C, Muhr D, Cerny H, Glueck S, et al;
Austrian Hereditary Breast and Ovarian Cancer Group. Prevalence of
pre-malignant and malignant lesions in prophylactic mastectomy
specimens of BRCA1 mutation carriers: Comparison with a control
group. J Cancer Res Clin Oncol. 134:1113–1121. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Arver B, Borg A and Lindblom A: First
BRCA1 and BRCA2 gene testing implemented in the health care system
of Stockholm. Genet Test. 5:1–8. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Arver B, Haegermark A, Platten U, Lindblom
A and Brandberg Y: Evaluation of psychosocial effects of
pre-symptomatic testing for breast/ovarian and colon cancer
pre-disposing genes: A 12-month follow-up. Fam Cancer. 3:109–116.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Zelada-Hedman M, Wasteson Arver B, Claro
A, Chen J, Werelius B, Kok H, Sandelin K, Håkansson S, Andersen TI,
Borg A, et al: A screening for BRCA1 mutations in breast and
breast-ovarian cancer families from the Stockholm region. Cancer
Res. 57:2474–2477. 1997.PubMed/NCBI
|
|
113
|
Arver B, Isaksson K, Atterhem H, Baan A,
Bergkvist L, Brandberg Y, Ehrencrona H, Emanuelsson M, Hellborg H,
Henriksson K, et al: Bilateral prophylactic mastectomy in Swedish
women at high risk of breast cancer: A national survey. Ann Surg.
253:1147–1154. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Brandt A, Lorenzo Bermejo J, Sundquist J
and Hemminki K: Breast cancer risk in women who fulfill high-risk
criteria: At what age should surveillance start? Breast Cancer Res
Treat. 121:133–141. 2010. View Article : Google Scholar
|
|
115
|
Czene K, Reilly M, Hall P and Hartman M: A
constant risk for familial breast cancer? A population-based family
study. Breast Cancer Res. 11:R302009. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Hemminki K, Ji J and Försti A: Risks for
familial and contralateral breast cancer interact multiplicatively
and cause a high risk. Cancer Res. 67:868–870. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Hemminki K, Mousavi SM, Sundquist J and
Brandt A: Does the breast cancer age at diagnosis differ by
ethnicity? A study on immigrants to Sweden. Oncologist. 16:146–154.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Margolin S, Werelius B, Fornander T and
Lindblom A: BRCA1 mutations in a population-based study of breast
cancer in Stockholm county. Genet Test. 8:127–132. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Von Wachenfeldt A, Brandberg Y, Johansson
H and Fornander T: Socioeconomic status and quality of life of
women with family history of breast cancer attending an oncogenetic
counseling clinic: A comparison with general population. Acta
Oncol. 48:86–92. 2009. View Article : Google Scholar
|
|
120
|
Dørum A, Heimdal K, Løvslett K, Kristensen
G, Hansen LJ, Sandvei R, Schiefloe A, Hagen B, Himmelmann A, Jerve
F, et al: Prospectively detected cancer in familial breast/ovarian
cancer screening. Acta Obstet Gynecol Scand. 78:906–911. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Hagen AI, Kvistad KA, Maehle L, Holmen MM,
Aase H, Styr B, Vabø A, Apold J, Skaane P and Møller P: Sensitivity
of MRI versus conventional screening in the diagnosis of
BRCA-associated breast cancer in a national prospective series.
Breast. 16:367–374. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Albrektsen G, Heuch I and Thoresen SØ:
Histological type and grade of breast cancer tumors by parity, age
at birth, and time since birth: A register-based study in Norway.
BMC Cancer. 10:2262010. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Foretova L, Petrakova K, Palacova M,
Kalabova R, Svoboda M, Navratilova M, Schneiderova M, Bolcak K,
Krejci E, Drazan L, et al: Genetic testing and prevention of
hereditary cancer at the MMCI--over 10 years of experience. Klin
Onkol. 23:388–400. 2010.
|
|
124
|
Foretova L, Machackova E, Navratilova M,
Pavlu H, Hruba M, Lukesova M and Valik D: BRCA1 and BRCA2 mutations
in women with familial or early-onset breast/ovarian cancer in the
Czech Republic. Hum Mutat. 23:397–398. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Mateju M, Stribrna J, Zikan M, Kleibl Z,
Janatova M, Kormunda S, Novotny J, Soucek P, Petruzelka L and
Pohlreich P: Population-based study of BRCA1/2 mutations: Family
history based criteria identify minority of mutation carriers.
Neoplasma. 57:280–285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Mulsow J, Lee J, Dempsey C, Rothwell J and
Geraghty JG: Establishing a family risk assessment clinic for
breast cancer. Breast J. 15(Suppl 1): S33–S38. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Brandt RT and Lynch HT: BRCA1 and BRCA2:
To test or not to test. Breast Cancer Res Treat. 67:187–188. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Surbone A: Ethical implications of genetic
testing for breast cancer susceptibility. Crit Rev Oncol Hematol.
40:149–157. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Márquez M, Belkić K, Nilsson S and
Holmberg AR: Genetic testing in patients with hereditary cancer
risk: Social, ethical and legal considerations. Instit Investig
Jurid. 383:295–340. 2007.
|
|
130
|
Baider L, Peretz T, Hadani PE, Perry S,
Avramov R and De-Nour AK: Transmission of response to trauma?
Second-generation Holocaust survivors' reaction to cancer. Am J
Psychiatry. 157:904–910. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Baider L, Goldzweig G, Ever-Hadani P and
Peretz T: Psychological distress and coping in breast cancer
patients and healthy women whose parents survived the Holocaust.
Psychooncology. 15:635–646. 2006. View Article : Google Scholar
|
|
132
|
Baider L, Goldzweig G, Ever-Hadani P and
Peretz T: Breast cancer and psychological distress: Mothers' and
daughters' traumatic experiences. Support Care Cancer. 16:407–414.
2008. View Article : Google Scholar
|
|
133
|
Keinan-Boker L, Vin-Raviv N, Liphshitz I,
Linn S and Barchana M: Cancer incidence in Israeli Jewish survivors
of World War II. J Natl Cancer Inst. 101:1489–1500. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Brown DR, Fouad MN, Basen-Engquist K and
Tortolero-Luna G: Recruitment and retention of minority women in
cancer screening, prevention, and treatment trials. Ann Epidemiol.
10(Suppl 8): S13–S21. 2000. View Article : Google Scholar
|
|
135
|
Newman LA, Hurd T, Leitch M, Kuerer HM,
Diehl K, Lucci A, Giuliano A, Hunt KK, Putnam W and Wells SA: A
report on accrual rates for elderly and minority-ethnicity cancer
patients to clinical trials of the American College of Surgeons
Oncology Group. J Am Coll Surg. 199:644–651. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Guevara C, Cook C, Herback N, Pietrobon R,
Jacobs DO and Vail TP: Gender, racial, and ethnic disclosure in NIH
K-Award funded diabetes and obesity clinical trials. Account Res.
13:311–324. 2006. View Article : Google Scholar
|
|
137
|
Azaiza F, Cohen M, Awad M and Daoud F:
Factors associated with low screening for breast cancer in the
Palestinian Authority: Relations of availability, environmental
barriers, and cancer-related fatalism. Cancer. 116:4646–4655. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Bobo JK, Shapiro JA and Brustrom J:
Efforts to locate low-income women for a study on mammography
rescreening: Implications for public health practice. J Community
Health. 31:249–261. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Garbers S, Jessop DJ, Foti H, Uribelarrea
M and Chiasson MA: Barriers to breast cancer screening for
low-income Mexican and Dominican women in New York City. J Urban
Health. 80:81–91. 2003.PubMed/NCBI
|
|
140
|
Otero-Sabogal R, Stewart S, Sabogal F,
Brown BA and Pérez-Stable EJ: Access and attitudinal factors
related to breast and cervical cancer rescreening: Why are Latinas
still under-screened? Health Educ Behav. 30:337–359. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Otero-Sabogal R, Owens D, Canchola J,
Golding JM, Tabnak F and Fox P: Mammography rescreening among women
of diverse ethnicities: Patient, provider, and health care system
factors. J Health Care Poor Underserved. 15:390–412. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Erwin DO, Johnson VA, Trevino M, Duke K,
Feliciano L and Jandorf L: A comparison of African American and
Latina social networks as indicators for culturally tailoring a
breast and cervical cancer education intervention. Cancer.
109(Suppl 2): 368–377. 2007. View Article : Google Scholar
|
|
143
|
Glanz K, Croyle RT, Chollette VY and Pinn
VW: Cancer-related health disparities in women. Am J Public Health.
93:292–298. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Meiser B, Eisenbruch M, Barlow-Stewart K,
Tucker K, Steel Z and Goldstein D: Cultural aspects of cancer
genetics: Setting a research agenda. J Med Genet. 38:425–429. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Remennick L: The challenge of early breast
cancer detection among immigrant and minority women in
multicultural societies. Breast J. 12(Suppl 1): S103–S110. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Valdez A, Banerjee K, Ackerson L and
Fernandez M: A multi-media breast cancer education intervention for
low-income Latinas. J Community Health. 27:33–51. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Borrayo EA: Where's Maria? A video to
increase awareness about breast cancer and mammography screening
among low-literacy Latinas. Prev Med. 39:99–110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Cohen M and Azaiza F: Increasing breast
examinations among arab women using a tailored culture-based
intervention. Behav Med. 36:92–99. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Jibaja-Weiss ML, Volk RJ, Kingery P, Smith
QW and Holcomb JD: Tailored messages for breast and cervical cancer
screening of low-income and minority women using medical records
data. Patient Educ Couns. 50:123–132. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Navarro AM, Senn KL, McNicholas LJ, Kaplan
RM, Roppé B and Campo MC: Por La Vida model intervention enhances
use of cancer screening tests among Latinas. Am J Prev Med.
15:32–41. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Remennick L: ‘I have no time for potential
troubles': Russian immigrant women and breast cancer screening in
Israel. J Immigr Health. 5:153–163. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Berg WA, Blume JD, Adams AM, Jong RA, Barr
RG, Lehrer DE, Pisano ED, Evans WP III, Mahoney MC, Hovanessian
Larsen L, et al: Reasons women at elevated risk of breast cancer
refuse breast MR imaging screening: ACRIN 6666. Radiology.
254:79–87. 2010. View Article : Google Scholar :
|
|
153
|
Yu J, Park A, Morris E, Liberman L, Borgen
PI and King TA: MRI screening in a clinic population with a family
history of breast cancer. Ann Surg Oncol. 15:452–461. 2008.
View Article : Google Scholar
|
|
154
|
Robson M: Breast cancer surveillance in
women with hereditary risk due to BRCA1 or BRCA2 mutations. Clin
Breast Cancer. 5:260–268; discussion 269–271. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Begley JK, Redpath TW, Bolan PJ and
Gilbert FJ: In vivo proton magnetic resonance spectroscopy of
breast cancer: A review of the literature. Breast Cancer Res.
14:2072012. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Belkić K and Belkić D: Possibilities for
improved early breast cancer detection by Padé-optimized magnetic
resonance spectroscopy. Isr Med Assoc J. 13:236–243. 2011.
|
|
157
|
Katz-Brull R, Lavin PT and Lenkinski RE:
Clinical utility of proton magnetic resonance spectroscopy in
characterizing breast lesions. J Natl Cancer Inst. 94:1197–1203.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Sardanelli F, Fausto A and Podo F: MR
spectroscopy of the breast. Radiol Med (Torino). 113:56–64. 2008.
View Article : Google Scholar
|
|
159
|
Tse GM, Yeung DK, King AD, Cheung HS and
Yang WT: In vivo proton magnetic resonance spectroscopy of breast
lesions: An update. Breast Cancer Res Treat. 104:249–255. 2007.
View Article : Google Scholar
|
|
160
|
O'Flynn EA, Wilson RM, Allen SD, Locke I,
Scurr E and deSouza NM: Diffusion-weighted imaging of the high-risk
breast: Apparent diffusion coefficient values and their
relationship to breast density. J Magn Reson Imaging. 39:805–811.
2014. View Article : Google Scholar
|
|
161
|
Eyal E, Shapiro-Feinberg M, Furman-Haran
E, Grobgeld D, Golan T, Itzchak Y, Catane R, Papa M and Degani H:
Parametric diffusion tensor imaging of the breast. Invest Radiol.
47:284–291. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Allgood PC, Warwick J, Warren RML, Day NE
and Duffy SW: A case-control study of the impact of the East
Anglian breast screening programme on breast cancer mortality. Br J
Cancer. 98:206–209. 2008. View Article : Google Scholar
|
|
163
|
Anttila A, Koskela J and Hakama M:
Programme sensitivity and effectiveness of mammography service
screening in Helsinki, Finland. J Med Screen. 9:153–158. 2002.
View Article : Google Scholar
|
|
164
|
Duffy SW, Tabár L, Chen HH, Holmqvist M,
Yen MF, Abdsalah S, Epstein B, Frodis E, Ljungberg E,
Hedborg-Melander C, et al: The impact of organized mammography
service screening on breast carcinoma mortality in seven Swedish
counties. Cancer. 95:458–469. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Gabe R, Tryggvadóttir L, Sigfússon BF,
Olafsdóttir GH, Sigurđsson K and Duffy SW: A case-control study to
estimate the impact of the Icelandic population-based mammography
screening program on breast cancer death. Acta Radiol. 48:948–955.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Morimoto T, Nagao T, Okazaki K, Kira M,
Nakagawa Y and Tangoku A: Current status of breast cancer screening
in the world. Breast Cancer. 16:2–9. 2009. View Article : Google Scholar
|
|
167
|
Sarkeala T, Anttila A, Saarenmaa I and
Hakama M: Validity of process indicators of screening for breast
cancer to predict mortality reduction. J Med Screen. 12:33–37.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Vahabi M: Breast cancer and screening
information needs and preferred communication medium among Iranian
immigrant women in Toronto. Health Soc Care Community. 19:626–635.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
|
|
170
|
Domingo L, Sala M, Servitja S, Corominas
JM, Ferrer F, Martínez J, Macià F, Quintana MJ, Albanell J and
Castells X: Phenotypic characterization and risk factors for
interval breast cancers in a population-based breast cancer
screening program in Barcelona, Spain. Cancer Causes Control.
21:1155–1164. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Vanags A, Štrumfa I, Gardovskis A,
Borošenko V, Aboliš A, Teibe U, Trofimovičs G, Miklaševičs E and
Gardovskis J: Population screening for hereditary and familial
cancer syndromes in Valka district of Latvia. Hered Cancer Clin
Pract. 8:82010. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Venturini E, Losio C, Panizza P,
Rodighiero MG, Fedele I, Tacchini S, Schiani E, Ravelli S, Cristel
G, Panzeri MM, et al: Tailored breast cancer screening program with
microdose mammography, US, and MR Imaging: Short-term results of a
pilot study in 40–49-year-old women. Radiology. 268:347–355. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Obralić N and Bešlija S: How to make the
best use of limited resources in breast cancer treatment -
experiences in Bosnia & Herzegovina. J BUON. 11:21–29.
2006.
|
|
174
|
Council of the European Union. Council
conclusions on reducing the burden of cancer. In: Employment,
Social Policy, Health and Consumer Affairs Council Meeting;
Luxembourg. June 10, 2008;
|
